Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
VERSA CAPITAL FUND III, L.P. - 11 Aug 2025 SCHEDULE 13G Report for Picard Medical, Inc. Common Stock, $0.0001 par value per share (PMI)
- Filing manager
- VERSA CAPITAL FUND III, L.P.
- Reporting owner
- Sindex SSI Lending, LLC
- Beneficially owned shares
- 7,943,585 shares
- Large-stake signal
-
Ownership
11%Beneficial ownership of this reported class.
Shares
7,943,585 sharesShares beneficially owned as disclosed.
Event date
11 Aug 2025Date tied to the ownership event or amendment.
Accepted by SEC
13 Nov 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 11%
- Symbol
- PMI
- Shares outstanding
- 73,551,713 shares
- SEC form
- SCHEDULE 13G
- Accepted by SEC
- 13 Nov 2025, 16:15:17 UTC
- Event date
- 11 Aug 2025
- Prior SEC filing
- 05 Jun 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Filing notes and source
Key filing fact
VERSA CAPITAL FUND III, L.P. disclosed 11% ownership in Picard Medical, Inc. Common Stock, $0.0001 par value per share (PMI) on 11 Aug 2025.
Key facts
- VERSA CAPITAL FUND III, L.P. filed SCHEDULE 13G for Picard Medical, Inc. Common Stock, $0.0001 par value per share (PMI).
- Disclosed ownership: 11%.
- Date of event: 11 Aug 2025.
Change
- Disclosed shares changed by 7,943,585 since the prior disclosure.
- Previous schedule filing date: 05 Jun 2026.
- Current filing was accepted on 13 Nov 2025, 16:15.
- Disclosed stake changed by 10.80 percentage points.
- Changes between disclosures can reflect transactions, share-count changes or reporting changes; they do not establish a purchase or activist intent.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (6)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sindex SSI Lending, LLC | 11% | 7,943,585 | 7,943,585 | 0 | /s/ Randall Schultz | Randall Schultz, as Attorney-in-Fact for: Sindex SSI Lending, LLC (1) | |
| Versa Capital Fund III, L.P. | 11% | 7,943,585 | 7,943,585 | 0 | /s/ Randall Schultz | Randall Schultz, as Attorney-in-Fact for: Versa Capital Fund III, L.P. (1) | |
| Versa FGP-III, L.P. | 11% | 7,943,585 | 7,943,585 | 0 | /s/ Randall Schultz | Randall Schultz, as Attorney-in-Fact for: Versa FGP-III, L.P. (1) | |
| Versa UGP-III, LLC | 11% | 7,943,585 | 7,943,585 | 0 | /s/ Randall Schultz | Randall Schultz, as Attorney-in-Fact for: Versa UGP-III, LLC (1) | |
| Versa Capital Group, LLC | 11% | 7,943,585 | 7,943,585 | 0 | /s/ Randall Schultz | Randall Schultz, as Attorney-in-Fact for: Versa Capital Group, LLC (1) | |
| Gregory L. Segall | 11% | 7,943,585 | 7,943,585 | 0 | /s/ Randall Schultz | Randall Schultz, as Attorney-in-Fact for: Gregory L. Segall (1) |
CIK / CUSIP context first